^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    inodiftagene vixteplasmid (BC 819)

    i
    Associations

    News

    Trials
    Company:
    ChemomAb
    Drug class:
    Gene transference
    Related drugs:
    Associations

    News

    Trials
    over4years
    Long non-coding RNA in bladder cancer. (PubMed, Clin Chim Acta)
    Moreover, antisense oligonucleotides (ASOs) and a double-stranded DNA plasmid (BC-819) have been designed for use in preclinical cancer models and clinical trials in patients. Therefore, the results of investigations have gradually prompted the utility of lncRNAs.
    Review • Journal
    |
    MALAT1 (Metastasis associated lung adenocarcinoma transcript 1) • H19 (H19 Imprinted Maternally Expressed Transcript)
    |
    inodiftagene vixteplasmid (BC 819)